Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sergiusz Nawrocki
Treatment Results, Including Clinical Prognostic Factors and MGMT Gene Promoter Methylation, in Patients With Glioblastoma Multiforme in Warmia and Mazury Oncology Centre
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging
Related publications
Personalized Treatment Strategies in Glioblastoma: MGMT Promoter Methylation Status
OncoTargets and Therapy
Oncology
Pharmacology
Prognostic Value of MGMT Promoter Methylation in Glioblastoma Patients Treated With Temozolomide-Based Chemoradiation: A Portuguese Multicentre Study
Oncology Reports
Medicine
Cancer Research
Oncology
The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis
PLoS ONE
Multidisciplinary
Efficacy of Clinical Prognostic Factors on Survival in Patients With Glioblastoma
Turkish Neurosurgery
Surgery
Neurology
MGMT Promoter Methylation Cutoff With Safety Margin for Selecting Glioblastoma Patients Into Trials Omitting Temozolomide. A Pooled Analysis of Four Clinical Trials.
Clinical Cancer Research
Cancer Research
Oncology
Prognostic Factors for Glioblastoma Multiforme: Development of a Prognostic Index
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Gene Expression and Promoter Methylation of Angiogenic and Lymphangiogenic Factors as Prognostic Markers in Melanoma
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Treatment Results and Prognostic Factors in 73 Patients With Nasopharyngeal Carcinoma.
Japanese jornal of Head and Neck Cancer
Prognostic or Predictive Value of MGMT Promoter Methylation in Gliomas Depends on IDH1 Mutation
Neurology
Neurology
